NCT07083856Recruiting
Effects of Reiki and Self-Acupressure Applications
Comparison of the Effects of Reiki and Self-Acupressure Applications on Functionality and Quality of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 24 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 17 Jul 2025
- Start date
- 20 Apr 2025
- Primary completion date
- 20 Jul 2025
- Lead sponsor
- Firat University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07083856
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 20 Apr 2025 to the primary completion date, 20 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have received corticosteroid treatment in the last three months
- Are taking psychostimulant medications
Other illness
- Have diabetes
- Have an autoimmune disease other than multiple sclerosis
- Have signs of infection
- Have another known neurological system disease (dementia, Alzheimer's, etc.)
Other
- Patients who smoke, use substances, or use tranquilizers
- Have dyspnea
- Have anemia
- Have had an MS attack in the last three months
- Have a thyroid problem
- Have anxiety or depression detected in outpatient clinic screenings
- Refuse to participate in the study
- Have a communication barrier will not be included in the study.
Who the study is looking for
- Patients who are willing to participate
- Patients who have no communication problems
- Patients who are 18 years of age or older
- Patients who live in the center
- Patients who have no scratches or deformities in the treatment area
- Patients who do not smoke, use drugs, or use tranquilizers, and are not pregnant
- Patients who have been receiving MS treatment for more than three months
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Muğla Sıtkı Koçman University Coordinator of this site? Confirm its status | Muğla | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.